| Edward Hendrik Fulton, MD | |
|
3550 Independence Dr, Birmingham, AL 35209 | |
| (205) 949-2806 | |
| (205) 949-2810 |
| Full Name | Edward Hendrik Fulton |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 11 Years |
| Location | 3550 Independence Dr, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447639125 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZD0900X | Pathology - Dermatopathology | MD.37372 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Skin Pathology Associates, Llc | 9537395652 | 6 |
News Archive
"After months of plodding work by five Congressional committees and weeks of back-room bargaining by Democratic leaders, President Obama's arms-length strategy on health care appears to be paying dividends, with the House and the Senate poised to take up legislation to insure nearly all Americans," The New York Times reports.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
In an advance toward the first portable device for detecting human bodies buried in disasters and at crime scenes, scientists today report early results from a project to establish the chemical fingerprint of death.
A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation and the Sbarro Institute for Cancer Research and Molecular Medicine report.
› Verified 5 days ago
| Entity Name | Skin Pathology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376970236 PECOS PAC ID: 9537395652 Enrollment ID: O20140110000745 |
News Archive
"After months of plodding work by five Congressional committees and weeks of back-room bargaining by Democratic leaders, President Obama's arms-length strategy on health care appears to be paying dividends, with the House and the Senate poised to take up legislation to insure nearly all Americans," The New York Times reports.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
In an advance toward the first portable device for detecting human bodies buried in disasters and at crime scenes, scientists today report early results from a project to establish the chemical fingerprint of death.
A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation and the Sbarro Institute for Cancer Research and Molecular Medicine report.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward Hendrik Fulton, MD 3560 Independence Dr, Birmingham, AL 35209-5703 Ph: (205) 949-2834 | Edward Hendrik Fulton, MD 3550 Independence Dr, Birmingham, AL 35209 Ph: (205) 949-2806 |
News Archive
"After months of plodding work by five Congressional committees and weeks of back-room bargaining by Democratic leaders, President Obama's arms-length strategy on health care appears to be paying dividends, with the House and the Senate poised to take up legislation to insure nearly all Americans," The New York Times reports.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
In an advance toward the first portable device for detecting human bodies buried in disasters and at crime scenes, scientists today report early results from a project to establish the chemical fingerprint of death.
A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation and the Sbarro Institute for Cancer Research and Molecular Medicine report.
› Verified 5 days ago
Dr. Kyle Charles Mills, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2800 Fax: 205-949-2801 | |
Leona Council, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5038 | |
Dr. Alexander Wong, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2806 Fax: 205-949-2875 | |
Dr. David Ullman, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-934-4977 | |
Dr. Jonathan G Phillips, MD Pathology Medicare: Medicare Enrolled Practice Location: 924 Montclair Rd, Ste 200, Birmingham, AL 35213 Phone: 205-591-7999 Fax: 205-591-5051 | |
Thomas S Winokur, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Isam Eltoum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 |